Labaton Keller Sucharow is pleased to present The Liaison: 2025 Mid-Year Report, our bi-annual update on non-U.S. securities litigation. With more than 20 years of experience abroad and deep relationships with law firms around the world, Labaton has a unique perspective on investment-related issues and recovery opportunities outside the United States. With our deep bench of litigators, combined with our offices located strategically across the globe, Labaton provides unparalleled insight into investment-related litigation and recovery opportunities for investors worldwide.
The Liaison: 2025 Mid-Year Report offers a deep dive into key developments shaping non-U.S. securities litigation.
This edition’s developments include:
Beyond noteworthy developments, the report also features case studies on new matters filed against STADA Arzneimittel AG in Germany and Southern Cross Payments Ltd. in Australia, highlighting the risks companies face in the current markets.
Additionally, the report analyzes securities litigation filing trends from 2021 to 2025 and offers a global snapshot of ongoing actions in key jurisdictions.
The Liaison contains exclusive insights and access is limited. To learn more about obtaining a copy, please contact Media@labaton.com.
Labaton Keller Sucharow is pleased to present The Liaison: 2025 Mid-Year Report, our bi-annual update on non-U.S. securities litigation. With more than 20 years of experience abroad and deep relationships with law firms around the world, Labaton has a unique perspective on investment-related issues and recovery opportunities outside the United States. With our deep bench of litigators, combined with our offices located strategically across the globe, Labaton provides unparalleled insight into investment-related litigation and recovery opportunities for investors worldwide.
The Liaison: 2025 Mid-Year Report offers a deep dive into key developments shaping non-U.S. securities litigation.
This edition’s developments include:
Beyond noteworthy developments, the report also features case studies on new matters filed against STADA Arzneimittel AG in Germany and Southern Cross Payments Ltd. in Australia, highlighting the risks companies face in the current markets.
Additionally, the report analyzes securities litigation filing trends from 2021 to 2025 and offers a global snapshot of ongoing actions in key jurisdictions.
The Liaison contains exclusive insights and access is limited. To learn more about obtaining a copy, please contact Media@labaton.com.
Labaton Keller Sucharow is pleased to present The Liaison: 2025 Mid-Year Report, our bi-annual update on non-U.S. securities litigation. With more than 20 years of experience abroad and deep relationships with law firms around the world, Labaton has a unique perspective on investment-related issues and recovery opportunities outside the United States. With our deep bench of litigators, combined with our offices located strategically across the globe, Labaton provides unparalleled insight into investment-related litigation and recovery opportunities for investors worldwide.
The Liaison: 2025 Mid-Year Report offers a deep dive into key developments shaping non-U.S. securities litigation.
This edition’s developments include:
Beyond noteworthy developments, the report also features case studies on new matters filed against STADA Arzneimittel AG in Germany and Southern Cross Payments Ltd. in Australia, highlighting the risks companies face in the current markets.
Additionally, the report analyzes securities litigation filing trends from 2021 to 2025 and offers a global snapshot of ongoing actions in key jurisdictions.
The Liaison contains exclusive insights and access is limited. To learn more about obtaining a copy, please contact Media@labaton.com.